Õþ²ßËٵݣº¹ú¼ÒÒ½±£¾ÖÒ»Á¬·¢ÎÄÍƶ¯DRGˢУ¬µÚËÄÅú¹ú¼Ò×éÖ¯¸ßÖµÒ½ÓúIJļ¯²É¿ª±ê
Ò½ÁÆÕþ²ß
-
¹ú¼ÒÒ½±£¾Ö»Ø¸´£ºÖ§³ÖÁ¢ÒìÒ½ÁÆÆ÷е£¬¿íÃâDRG
12ÔÂ15ÈÕ£¬¹ú¼ÒÒ½±£¾ÖÐû²¼ÁË¡¶¹ØÓÚÕþÐÊ®ËĽìÌìÏÂίԱ»áµÚÒ»´Î¾Û»áµÚ02870ºÅ£¨Éç»áÖÎÀíÀà217ºÅ£©Ìá°¸»Ø¸´µÄº¯¡·£¬Ã÷È·Ìá³ö¡°ÃãÀø½«ÐÂÊÖÒÕ¡¢ÐÂÒ©Æ·¡¢ÐÂÆ÷еÄÉÈë°ü¹Ü¹æÄ££¬Òý·¢Ò©Æ·ÆóÒµÁ¢ÒìÑз¢¶¯Á¦£»ÔÚDRG/DIPµÈÒ½±£Ö§¸¶·½·¨Ë¢ÐÂÖУ¬³ä·Ö˼Á¿ÐÂÊÖÒÕ¡¢ÐÂÒ©Æ·¡¢ÐÂÆ÷еµÄÓ¦Ó㬿Æѧ²âË㲡ÖÖ·ÖÖµ£¬²¢½¨É趯̬µ÷½â»úÖÆ¡£¡± »Ø¸´º¯Ç¿µ÷£¬DRG/DIPÖ§¸¶·½·¨Ë¢ÐµÄÄ¿µÄÊÇ¡°µ½2025Äêµ×ÁýÕÖËùÓÐÇкÏÌõ¼þµÄÒ½ÁÆ»ú¹¹¡±¡£
½ñÄêÄêÍ·£¬¹ú¼ÒÒ½±£¾ÖµãÃûÖ§³ÖµØ·½Ò½±£²¿·ÖÔÚÊÔµãÊÂÇéÖн¨ÉèCHS-DRG¸¶·ÑÖ§³ÖÒ½ÁÆÐÂÊÖÒյĻúÖÆ¡£7Ô£¬±±¾©×÷ΪÊԵ㶼»áÐû²¼ÁË¡¶¹ØÓÚÓ¡·¢CHS-DRG¸¶·ÑÐÂÒ©ÐÂÊÖÒÕ³ýÍâÖ§¸¶ÖÎÀí²½·¥µÄ֪ͨ¡·£¬Ã÷È·Ìá³ö¡°ÊÔÐв»°´DRG·½·¨Ö§¸¶Á¢ÒìÒ©¡¢Á¢ÒìÒ½ÁÆÆ÷е¡¢Á¢ÒìÒ½ÁÆЧÀÍÏîÄ¿£¬¶øÊǽÓÄɵ¥¶À¾Ýʵ֧¸¶µÄ·½·¨¡±¡£
Õþ²ßÆÊÎö£º
£¨1£©ÔÚ½ñÄê×ÊÔ´Êг¡ÕûÌåÆ£ÈíµÄÌåÏÖÏ£¬¹ú¼ÒÒ½±£¾Ö¶à´ÎÁÁÏàDRG/DIPË¢ÐÂÎȲ½Íƽø£¬¹ØÓÚ±£»¤º£ÄÚÒ½ÁÆÁ¢ÒìÆø·Õ¾ßÓÐÖ÷ÒªÒâÒ壬Ϊ¸ßÖµÁ¢ÒìÒ½ÁƲúÆ·Ò»Á¬ÌṩÊг¡¿Õ¼ä
-
¹ãÖÝÍ·²¿Èý¼×ҽԺͬÃ˼¯½ÓÄÉÈë¸ßÖµºÄ²ÄÐÂÃæÄ¿
12ÔÂ13ÈÕ£¬¹ã¶«Ê¡¹ãÖݹ«¹²×ÊÔ´ÉúÒâÖÐÐÄÐû²¼¡¶¹ãÖÝÒ½ÓúIJÄÒ½ÁÆ»ú¹¹ÍŽá²É¹ºÎļþ£¨¾µ¼¹ÜÈ˹¤×Ô¶¯Âö°êĤÖû»ÏµÍ³¡¢¿É³äµçÖ²ÈëʽÄÔÉµç´Ì¼¤¡¢ÑªÁ÷µ¼ÏòÃÜÍøÖ§¼Ü£©£¨Õ÷ÇóÒâ¼û¸å£©¡·¡£±¾´Î²É¹ºÖ÷ÌåΪÖÐɽ´óѧÁ¥ÊôµÚÒ»Ò½Ôº¡¢¹ã¶«Ê¡ÈËÃñÒ½Ôº¡¢ÖÐɽ´óѧËïÒÝÏɼÍÄîÒ½Ôº¡¢ÖÐɽ´óѧÁ¥ÊôµÚÈýÒ½Ôº¡¢ÖÐɽ´óѧÁ¥ÊôµÚÁùÒ½Ôº¡¢ôßÄÏ´óѧÁ¥ÊôµÚÒ»Ò½Ôº¡¢¹ãÖÝÒ½¿Æ´óѧÁ¥ÊôµÚÒ»Ò½ÔºµÈ7¼ÒÒ½Ôº£¬ÍŽá²É¹ºÖÜÆÚΪ1Äê¡£±¾´Î¼¯²ÉÈý´óÀàºÄ²ÄÖУ¬ÑªÁ÷µ¼ÏòÃÜÍøÖ§¼ÜÔÚºÓÄϺͱ±¾©µÄҽԺͬÃ˾ùÒÑ·ºÆð¹ý£¬¶øTAVI¡¢DBSÔòÊôÓÚ¼¯²ÉµÄÐÂÏÊÃæÄ¿£¬Ê״ηºÆð¡£
Õþ²ßÆÊÎö£º
£¨1£©?Ïֽ׶ÎTAVI¡¢DBSµÈ¸ßÖµºÄ²ÄÈÔÈ»Ö÷ÒªÓÃÓÚº£ÄÚ¶¥¼âµÄÈý¼×Ò½Ôº£¬Êг¡ÉÐδ·¿ª¡£½ñÄê6Ô£¬±±¾©´óÈý¼×ͬÃ˲ɹºÉñ¾½éÈëÀà¸ß²Åƽ¾ù½µ·ùΪ20%£¬×÷Ϊ²Î¿¼£¬±¾´Î¼¯²É¹ØÓÚTAVI¡¢DBS¹ú²ú³§ÉÌÒ²ÊÇË«Èн££¬¹ú²ú³§ÉÌÔõÑùÒÔ¼Û»»Á¿£¬ÕÆÎÕ½øԺʱ»ú£¬ÖµµÃÆÚ´ý¡£
-
Õã½Ê¡Ò½±£¾Ö¾ÍDRG¼¤ÀøÕ÷ÇóÒâ¼û
12ÔÂ8ÈÕ£¬Õã½Ê¡Ò½±£¾ÖÐû²¼¡¶Õã½Ê¡Á¢ÒìÒ½Ò©ÊÖÒÕÒ½±£Ö§¸¶¼¤ÀøÖÎÀí²½·¥£¨ÊÔÐУ©£¨Õ÷ÇóÒâ¼û¸å£©¡·¡£¹ØÓÚÖª×ãÒªÇóµÄÁ¢ÒìÆ÷еÌá¸ß¼¤Àø×ܶ¸÷ÉèÇøÊÐÒ½±£²¿·Ö¿É°´½ñÄê¶ÈDRGÕûÀí×ܶîµÄÒ»¶¨±ÈÀýÈ·¶¨¼¤Àø×ܶ²¢ÎȲ½¼Ó´ó¼¤ÀøÁ¦¶È¡£¶Ô¹ú¼Ò¡¢Ê¡ÖصãʹÃüµÄ¶¨µãÒ½ÁÆ»ú¹¹µÄ¸ß¶ËÐÂÊÖÒÕºÍÖÐÒ½Ò©ÐÂÊÖÒÕ£¬Êʵ±ÑÓÉìÒ»ÄêÍËÆÂʱ¼ä¡¢Ìá¸ß¼¤ÀøϵÊý¡£
£¨1£©ÕûÌåÉÏÀ´¿´£¬´Ë´Î¼¤ÀøÖ÷ÒªÕë¶Ô¸ß¶ËÁ¢ÒìÒ½ÁÆÆ÷е£¬µ÷½âÁ¦¶È½ÏΪÎÂ˳
-
µÚËÄÅú¹ú¼Ò×éÖ¯¸ßÖµÒ½ÓúIJļ¯²É¿ª±ê
11ÔÂ30ÈÕ£¬µÚËÄÅú¹ú¼Ò×éÖ¯¸ßÖµÒ½ÓúIJļ¯²É¿ª±ê£¬´Ë´Î¼¯²ÉÁýÕֵĸßÖµÒ½ÓúIJÄÆ·ÖÖÖ÷Òªº¸ÇÈ˹¤¾§ÌåÀࣨ11ÖÖ£©ºÍÔ˶¯Ò½Ñ§ÀàºÄ²Ä£¨20ÖÖ£©ºÏ¼Æ31¸ö¸ßÖµÒ½ÓúIJÄÏà¹ØÆ·ÖÖ£¬Éæ¼°¼ÓÈëÆóÒµÊýÄ¿128¼Ò£¬ÖÐÑ¡ÆóÒµÊýĿΪ126¼Ò£¬ÖÐÑ¡Âʵִï98%¡£
½µ¼Û·ù¶È·½Ã棬È˹¤¾§ÌåÀàÀàºÄ²Äƽ¾ù½µ¼Û·ù¶ÈΪ60%¡¢Ô˶¯Ò½Ñ§ÀàºÄ²Äƽ¾ù½µ¼Û·ù¶ÈΪ74%£¬ËùÓиßÖµºÄ²ÄÕûÌå½µ¼Û·ù¶ÈԼΪ70%¡£¼¯²ÉµÄÆ·ÖÖÑ¡ÔñÁË»¼Õß»ùÊý´ó¡¢ÐèÇóÊýÄ¿¶àµÄÈ˹¤¾§ÌåÀàºÄ²Ä£¬ÒÔ¼°×÷Ϊ´ËÇ°È˹¤ÊàŦºÍ¼¹ÖùÀàºÄ²Ä½øÒ»²½Ôö²¹Ð͵ÄÔ˶¯Ò½Ñ§ÀàºÄ²Ä¡£
£¨1£©ÆóÒµÖÐÑ¡Âʽϸߣ¬¸ßÖµºÄ²Ä½µ¼Û·ù¶ÈÇ÷ÓÚÎÂ˳£¬±£»¤Á¢ÒìÐͲúÆ·ÀûÈó¿Õ¼ä£¬ÊµÏÖ¹ú²úÌæ»»
£¨2£©È˹¤¾§ÌåÀàºÍÔ˶¯Ò½Ñ§ÀàºÄ²Ä¼¯²ÉµÄÀֳɿª±ê£¬½«½øÒ»²½Êͷż¯²ÉˢеÄÖƶÈÐÔÓ¯Àû£¬¼õÇáȺÖڼ縺
-
²ÆÎñ²¿ÖúÁ¦Î÷ÄÏÎ÷±±µØÇøÖÝÀïÎÀÉúÔº²É¹ºÒ½ÁÆ×°±¸
11ÔÂ3ÈÕ²ÆÎñ²¿Ðû²¼¡¶Í¨Öª¡·ÖúÁ¦Î÷ÄÏÎ÷±±µØÇøÖÝÀïÎÀÉúÔº²É¹ºÒ½ÁÆ×°±¸£¬Ö÷ÒªÓÃÓÚÖ§³ÖÎ÷²¿µØÇø¾àÀëÏسǽÏÔ¶¡¢Ð§ÀÍÉú³Ý½Ï¶à¡¢ÕïÁÆÌõ¼þÓдýÌáÉýµÄÖÝÀïÎÀÉúÔºÉèÖÃÉý¼¶Ò½ÁÆ×°±¸£¬ÌáÉý»ù±¾ÕïÁÆÄÜÁ¦¡£¸ÃÏî×ʽð½òÌù½«ÓÃÓÚÎ÷ÄÏÎ÷±±µØÇøΪÖ÷µÄ13µØµÄ228¼ÒÖÝÀïÎÀÉúÔº£¬Æ½¾ùÿ¼Ò½«»ñµÃ200ÍòµÄ½òÌù×ʽð¡£
£¨1£©ÓÐÍû·¿ªº£ÄÚϲãÊг¡£¬ÊµÏÖÒ½ÁÆ×ÊԴϳÁµ½ÖÝÀïÎÀÉúÔº£º×÷ΪϲãÒ½ÁÆЧÀÍϵͳµÄÊàŦ£¬ÖÝÀïÎÀÉúÔºÆðµ½ÁË¡°³ÐÉÏÆôÏ¡±µÄÖ÷Òª×÷Óã¬Ëæ׏ú¼Ò¡°Ç¿Ï²㡱Õþ²ßµÄÒ»Ö±ÂäµØ£¬ÌìÏÂ3.6Íò¼ÒÖÝÀïÎÀÉúÔºÆñÂÛÊÇÕïÁÆЧÀÍÄÜÁ¦ÕÕ¾ÉÒ½ÁÆ×°±¸´¢±¸Ò²½«»ñµÃÖÜÈ«ÌáÉý¡£
£¨2£©ÓÐÍû·¿ªº£ÄÚϲãÊг¡£¬ÊµÏÖÒ½ÁÆ×ÊԴϳÁµ½ÖÝÀïÎÀÉúÔº£º×÷ΪϲãÒ½ÁÆЧÀÍϵͳµÄÊàŦ£¬ÖÝÀïÎÀÉúÔºÆðµ½ÁË¡°³ÐÉÏÆôÏ¡±µÄÖ÷Òª×÷Óã¬Ëæ׏ú¼Ò¡°Ç¿Ï²㡱Õþ²ßµÄÒ»Ö±ÂäµØ£¬ÌìÏÂ3.6Íò¼ÒÖÝÀïÎÀÉúÔºÆñÂÛÊÇÕïÁÆЧÀÍÄÜÁ¦ÕÕ¾ÉÒ½ÁÆ×°±¸´¢±¸Ò²½«»ñµÃÖÜÈ«ÌáÉý¡£
×ʽðÕÙļÇéÐÎ
- ÆÕÂå˹×îÐÂÒ»ÆÚÖйúÊÕÒæ»ù½ðÍê³ÉÕÙļ£¬Í¶×ʹæÄ£54ÒÚÔª
11ÔÂ25ÈÕ£¬ÆÕÂå˹GLP×îÐÂÒ»ÆÚÖйúÊÕÒæ»ù½ðÍê³ÉÕÙļ£¬Í¶×ʹæÄ£´ï54ÒÚÔª¡£¸Ã»ù½ðͶ×ÊÈËΪº£ÄÚÁìÏȵİü¹Ü»ú¹¹£¬ÆÕÂå˹µ£µ±»ù½ðÖÎÀíÈËÒÔ¼°×ʲúÖÎÀíÈË¡£¸Ã»ù½ðÊÇÆÕÂå˹±¾¼¾¶ÈÔÚÖйúÍê³ÉÕÙļµÄµÚ¶þÖ§ÊÕÒæÐÍ»ù½ð£¬Í¶×ÊÓÚÉϺ£¡¢Çൺ¡¢Î人¡¢³¤É³µÈÎïÁ÷½¹µãÊàŦµÄ13´¦ÎȹÌÔËÓªµÄÏÖ´ú»¯ÎïÁ÷»ù´¡ÉèÊ©¡£Ô°ÇøÖ÷ҪЧÀÍÓÚÆû³µ¼°ÁãÅä¼þ¡¢»úеÖÆÔì¡¢µç×ÓµçÆ÷¡¢Ò½Ò©¼°Ò½ÁÆ×°±¸µÈ¸ß¶ËÖÇÄÜÖÆÔìÒµ£¬ÉÐÓÐÐÂÖÊÁÏ¡¢¹¤Òµ»úеÈË¡¢°ëµ¼ÌåµÈÐÂÐ˹¤Òµ£¬º¸ÇÖйú¾¼ÃÉý¼¶×ªÐ͵ÄÖ÷ÒªÁìÓò¡£
- Ê×ÆÚ¹æÄ£51ÒÚÔª£¬³¤Èý½ÇרÏî»ù½ðÕýʽ½¨Éè
11ÔÂ23ÈÕ£¬ÌìÏÂÉç±£»ù½ð³¤Èý½Ç¿Æ¼¼Á¢Òì¹ÉȨͶ×Ê»ù½ðÔÚÉϺ£¾ÙÐнÒÅÆÒÇʽ£¬Ê×ÆÚ¹æÄ£51ÒÚÔª£¬IDG×ÊÔ´µ£µ±»ù½ðÖÎÀíÈË¡£»ù½ð½«ÍŽá¹ú¼Ò¹¤ÒµÉú³¤Õþ²ßºÍ³¤Èý½ÇµØÇøÕ½ÂÔÉú³¤Æ«Ïò£¬ÖصãΧÈƼ¯³Éµç·¡¢ÉúÎïÒ½Ò©¡¢È˹¤ÖÇÄÜ¡¢µç×ÓÐÅÏ¢¡¢ÉúÃü¿µ½¡¡¢ÐÂÄÜÔ´Æû³µ¡¢¸ß¶Ë×°±¸¡¢ÏȽøÖÊÁÏ¡¢ÎïÁªÍø¡¢´óÊý¾Ý¡¢ÖÇÄÜÖÆÔìµÈÖصãÁìÓò¿ªÕ¹Í¶×ʽṹ£¬¼ÓËÙ¹¹½¨ÏÖ´ú»¯¹¤ÒµÏµÍ³¡£
-
Çຣʡĸ»ù½ðÍê³É±¸°¸£¬×ܹæÄ£50ÒÚÔª
11ÔÂ22ÈÕ£¬ÇຣÊ׸öÕþ¸®Í¶×Êĸ»ù½ð¡ª¡ªÇຣʡ¸ßÖÊÁ¿Éú³¤Õþ¸®Í¶×Ê»ù½ð£¨¼ò³Æ¡°Çຣʡĸ»ù½ð¡±£©ÔÚÖйú֤ȯͶ×Ê»ù½ðҵлáÍê³É±¸°¸¡£»ù½ðÓÉÇຣ½ð²Æ˽ļͶ×Ê»ù½ðÖÎÀíÓÐÏÞ¹«Ë¾µ£µ±ÖÎÀíÈË£¬ÈϽɹæÄ£50ÒÚÔª£¬ÆäÖÐÊ×ÆÚ³ö×Ê15ÒÚÔªÒÑʵ½Éµ½Î»£¬²¢¶¨Î»Îª×¤×ãÇຣÌØÓÐ×ÊÔ´Ù÷¸³£¬¾Û½¹¹¤Òµ¡°Ëĵء±¿ªÕ¹Í¶×Ê£¬Í¬Ê±Ö§³ÖÖÐСÆóÒµ¼°Á¢Òì´´ÒµÉú³¤£¬°üÀ¨ÌØÉ«ÐÂÖÊÁÏ¡¢×°±¸ÖÆÔìÉý¼¶¡¢¸ßÔÉúÎïºÍ¿µÑø¹¤Òµ¼°Êý×Ö¹¤Òµ»¯µÈ£¬¶ÔÖ§³Ö¡°Ëĵء±½¨ÉèµÄ×Ó»ù½ðͶ×Ê×ܶî¶È²»µÍÓÚ70%¡£
- Ԫϣº£ºÓ»ù½ðÍê³É±¸°¸£¬¹æÄ£5ÒÚÔª
11ÔÂ8ÈÕÐÂÎÅ£¬ÔªÏ£º£ºÓÉúÎïÒ½Ò©¹¤Òµ»ù½ðÕýʽÐû²¼Íê³ÉÖлùб¸°¸£¬×ܹæÄ£5ÒÚÔªÈËÃñ±Ò¡£»ù½ðΪ½ðɳ½ÍŽá×ÊÔ´¼Ì¡°Èóè±Ò½ÁÆ»ù½ð¡±ºóÐû²¼µÄµÚ¶þ֧רעÓÚͶ×ÊÉúÃü¿ÆѧºÍÒ½ÁÆ¿µ½¡ÐÐÒµµÄÒ½ÁÆ»ù½ð£¬×¨×¢ÓÚͶ×ÊÉúÃü¿ÆѧºÍÒ½ÁÆ¿µ½¡ÐÐÒµ£¬ÖصãͶ×ÊÁìÓò°üÀ¨Á¢ÒìÒ©¡¢ÉúÎïÊÖÒÕ¼°Ïà¹Ø¹¤ÒµÁ´¡£±¾´ÎÕÙļԪϣº£ºÓ»ù½ð»ñµÃ¶à¼ÒÕþ¸®Ö¸µ¼»ù½ðºÍÒ½Áƹ¤Òµ·½µÄ¶¦Á¦´ó¾ÙÖ§³Ö£¬ÆäÖаüÀ¨¿µÏ£ÅµÉúÎï¹É·Ý¹«Ë¾¡¢Ìì½òÊк£ºÓ¹¤Òµ»ù½ðµÈ¡£
?ÐÂҩתÈûØÊ×
±í1£º11ÔÂÐÂÒ©License in / License outÏîÄ¿Ò»ÀÀ
Ò»¼¶Êг¡º£ÄÚÍâÒ½ÁÆÁìÓòÈÚ×Ê
3.1. º£ÄÚÒ½ÁÆÈÚ×Ê£ºÖصã¹Ø×¢Á¢ÒìÒ©Îï¡¢½á¹¹ÐÔÐÄÔಡÀàÆ÷е
2023Äê11Ô£¬º£ÄÚÒ»¼¶Êг¡Í¶×Ê102¼ÒÒ½ÁÆÆóÒµ¡£±¾Ô£¬ÉúÎïҽҩͶ×ÊÏîÄ¿¶à¼¯ÖÐÓÚÁ¢ÒìÒ©ÎïÑз¢Æ«Ïò£»Ò½ÁÆÆ÷е·½Ã棬¶à¼ÒѪ¹Ü½éÈëÀàÆ÷е¹«Ë¾Åû¶ÈÚ×Ê¡£
ͼ1£º2023Äê11Ôº£ÄÚÒ½ÁÆ¿µ½¡ÁìÓòͶ×ÊÖ÷ÒªÂþÑÜÔÚÉúÎïÒ½Ò©¡¢Ò½ÁÆÆ÷е£º
±í2£º11Ôº£ÄÚÉúÎïÒ½Ò©¼°ÉÏÓÎÁìÓòÈÚ×ÊÏîÄ¿Ò»ÀÀ
±í3£º11Ôº£ÄÚÒ½ÁÆÆ÷еÁìÓòÈÚ×ÊÏîÄ¿Ò»ÀÀ
±í5£º11Ôº£ÄÚÒ½ÁÆЧÀÍÁìÓòÈÚ×ÊÏîÄ¿Ò»ÀÀ
±í6£º11Ôº£ÄÚÊý×ÖÒ½ÁƺÍÆäËûÁìÓòÈÚ×ÊÏîÄ¿Ò»ÀÀ
3.2 ÍâÑóÒ½ÁÆÈÚ×Ê£ºÖصã¹Ø×¢ÉúÎïÊÖÒÕÁìÓò
±¾Ô£¬ÍâÑóÒ½ÁÆÈÚ×ÊÈÈ°ñÖ®Ê×À´×Ô²¢¹º£¬Ä¬É³¶«Ðû²¼ÒÔ6.1ÒÚÃÀÔªÊÕ¹ºÉúÎïÊÖÒÕ¹«Ë¾Caraway Therapeutics¡£×ݹ۱¾ÔÂͶÈÚ×ÊÊÂÎñ£¬ÉúÎïÊÖÒÕÊÇÍâÑóͶ×Ê»ú¹¹Öصã¹ØעƫÏò¡£ÆäÖÐUniversal DX£¨UDX£©»ñµÃÀ´×ÔQuest DiagnosticsµÄ7000ÍòÃÀÔªBÂÖ×¢×Ê¡£UDXÖÂÁ¦ÓÚͨ¹ýÔçÆÚ¼ì²â½«°©Ö¢×ª±äΪ¿ÉÖÎÓúµÄ¼²²¡£¬ÏÖÔÚ£¬UDXÖ÷ҪרעÓÚ½áÖ±³¦°©µÄ¼ì²â£¬µ«ÆäÊÖÒÕÇ徲̨Ҳ¿ÉÒÔÓÃÓÚʶ±ðÓëÆäËû¸ß¼ç¸º°©Ö¢Ïà¹ØµÄÆæÒìDNAÐòÁÐÇøÓò¡£×¨×¢ÓÚ¿ª·¢ÐÂÐÍС·Ö×ÓÒ©ÎïµÄÉúÎïÊÖÒÕ¹«Ë¾Gate BioscienceÐû²¼»ñµÃÀ´×ÔVersant VenturesºÍGoogle VenturesÁìͶµÄ6000ÍòÃÀÔªAÂÖ×¢×Ê¡£Gate BioscienceµÄ·Ö×ÓÃÅ¿Ø·¢Ã÷ƽ̨£¨Molecular Gate Discovery Platform£©¿ÉÒÔ¸ßͨÁ¿É¸Ñ¡Ð¡·Ö×ÓÎĿ⣬²¢¶ÔÕû¸öÉø͸ÂÑ°××é¾ÙÐÐÖÜÈ«¡¢¶¨Á¿µÄÆÊÎö£¬ÒÔ¿ª·¢Ñ¡ÔñÐÔÁÆ·¨¡£ÕâÏîÊÖÒÕÓÐDZÁ¦¸Ä±äÏÖÔÚ¶ÔÖ÷Òª¼²²¡µÄÖÎÁÆ·½·¨£¬Îª»¼Õß´øÀ´Ï£Íû¡£2023Äê11ÔÂ22ÈÕ£¬ÉúÎ﹤³ÌÊÖÒÕ¹«Ë¾VivodyneÐû²¼Íê³ÉÁË×ܶî3800ÍòÃÀÔªµÄÖÖ×ÓÂÖÈÚ×Ê¡£Õâ±Ê×ʽðÓÉKhosla VenturesÁìͶ£¬Kairos Ventures¡¢CS Ventures¡¢MBX CapitalºÍBison Ventures¼ÓÈëͶ×Ê¡£Vivodyneͨ¹ýÉúÎ﹤³ÌÖÆÔìÁË20¶àÖÖ²î±ðÀàÐ͵ÄÈËÌåÆ÷¹Ù×éÖ¯£¬ÕâЩ×éÖ¯Äܹ»Ä£ÄâÈËÌåµÄÐÄÀíºÍ¹¦Ð§¡£¹«Ë¾µÄƽ̨Äܹ»×÷ÓýºÍÆÊÎöÁè¼Ý10,000¸öµ¥¶ÀµÄÈËÀà×éÖ¯£¬Ê¹ÓûúеÈË×Ô¶¯»¯ÊÖÒÕ¾ÙÐвÙ×÷¡£ÕâÑù¿ÉÒÔ±¬·¢´ó×ÚµÄÈËÀàÊý¾Ý¼¯£¬Ö§³ÖÏÂÒ»´úÒÔÈËΪѵÁ·µÄÈ˹¤ÖÇÄÜÒ©Îï·¢Ã÷¡£
±í7£º11ÔÂÍâÑóÒ½ÁÆ¿µ½¡×ÅÃû»ú¹¹Í¶×ÊÏîÄ¿Ò»ÀÀ
IPOºÍ²¢¹º
4.1 IPO£ºÒ½Áƹ«Òæ×éÖ¯DocolaÌá½»ÉÏÊÐÉêÇ룬ҩÃ÷ºÏÁª¸Û¹ÉÉÏÊÐ
11Ô£¬ÄÉ˹´ï¿Ë3¼Ò¹«Ë¾É걨IPO£¬ÃÀ½»Ëù1¼Ò¹«Ë¾É걨£¬Ïã¸ÛÖ÷°å1¼Ò¹«Ë¾É걨¡£ÃÀ¹É·½Ã棬ÁÙ´²½×¶ÎÖÆÒ©¹«Ë¾Sequoia Vaccines¡¢Ï¸°ûÁÆ·¨¹«Ë¾FibroBiologics¡¢ÐÂÐÍС·Ö×ÓÑз¢¹«Ë¾Telomir Pharmaceuticals¡¢ÓëÒ½Áƹ«Òæ×éÖ¯DocolaÌá½»ÉÏÊÐÉêÇë¡£º£ÄÚÉÏÊз½Ã棬±¾ÔÂÉÏÊÐ1¼ÒÆóÒµÒ©Ã÷ºÏÁª¡£ÍâÑóÉÏÊз½Ã棬ÃÀ¹úÉúÒâËùÉÏÊÐ2¼ÒÉúÎï¿Æ¼¼ÆóÒµ£¬Mural OncologyÓëCARGO Therapeutics¡£
±í8£º11ÔÂA¹É¡¢¸Û¹É¡¢ÃÀ¹ÉIPOÉ걨һÀÀ
±í9£º11ÔÂA¹É¡¢¸Û¹É¡¢ÃÀ¹ÉÉÏÊÐÒ»ÀÀ
4.2 ²¢¹º£ºÖÇ·ÉÉúÎïÊÕ¹ºå·°²ÉúÎï100%¹ÉȨ£¬½á¹¹Î÷Ò©ÁìÓò
±í10£º11ÔÂA¹É¡¢¸Û¹É²¢¹ºÒ»ÀÀ
ÃâÔðÉùÃ÷
Ïà¹ØÄÚÈÝ»ùÓÚÒѹûÕæµÄ×ÊÁÏ»òÐÅϢ׫д£¬µ«±¾¹«Ë¾²»°ü¹Ü¸ÃµÈÐÅÏ¢¼°×ÊÁϵÄÍêÕûÐÔ¡¢×¼È·ÐÔ£¬Ëùº¬ÐÅÏ¢¼°×ÊÁϼá³ÖÔÚ×îÐÂ״̬¡£Í¬Ê±£¬±¾¹«Ë¾ÓÐȨ¶Ô±¾±¨¸æËùº¬ÐÅÏ¢ÔÚ²»·¢³ö֪ͨµÄÇéÐÎÏÂ×ö³öÐ޸ģ¬ÔĶÁÕßÓ¦µ±×ÔÐйØ×¢ÏìÓ¦µÄ¸üлòÐ޸ġ£ÔÚÈκÎÇéÐÎÏ£¬±¾ÆªÎÄÕÂÖеÄÐÅÏ¢»òËù±íÊöµÄÒâ¼û¾ù²»×é³É¶ÔÈκÎÈ˵ÄͶ×ʽ¨Ò飬ÎÞÂÛÊÇ·ñÒѾÕÑʾ»òÌåÏÖ£¬±¾±¨¸æ²»¿É×÷ΪµÀÒåµÄ¡¢ÔðÈεĺÍÖ´·¨µÄÒÀ¾Ý»òÕßƾ֤¡£ÔÚÈκÎÇéÐÎÏ£¬±¾¹«Ë¾Òà²î³ØÈκÎÈËÒòʹÓñ¾ÎÄÕÂÖеÄÈκÎÄÚÈÝËùÒýÖµÄÈκÎËðʧ¸ºÈκÎÔðÈΡ£±¾ÎÄÕ½öΪ±¾¹«Ë¾ËùÓУ¬Î´¾ÊÂÏÈÊéÃæÔÊÐí£¬Èκλú¹¹ºÍСÎÒ˽¼Ò²»µÃÒÔÈκÎÐÎʽ·°æ¡¢¸´ÖÆ¡¢½ÒÏþ¡¢×ª·¢»òÒýÓñ¾±¨¸æµÄÈκβ¿·Ö¡£